C
12.79
-0.24 (-1.84%)
| Penutupan Terdahulu | 13.03 |
| Buka | 12.96 |
| Jumlah Dagangan | 3,307,572 |
| Purata Dagangan (3B) | 3,251,179 |
| Modal Pasaran | 954,760,704 |
| Harga / Pendapatan (P/E TTM) | 16.40 |
| Harga / Pendapatan (P/E Ke hadapan) | 6.25 |
| Harga / Jualan (P/S) | 6.95 |
| Harga / Buku (P/B) | 4.38 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Oct 2025 |
| Margin Keuntungan | 20.81% |
| Margin Operasi (TTM) | 51.49% |
| EPS Cair (TTM) | 0.250 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.41% |
| Nisbah Semasa (MRQ) | 4.21 |
| Aliran Tunai Operasi (OCF TTM) | -13.57 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -21.07 M |
| Pulangan Atas Aset (ROA TTM) | 8.31% |
| Pulangan Atas Ekuiti (ROE TTM) | 19.87% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menurun |
| Biotechnology (Global) | Bercampur | Menurun | |
| Stok | CorMedix Inc. | Menaik | Menaik |
AISkor Stockmoo
0.8
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | -2.5 |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.5 |
| Purata | 0.80 |
|
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company’s focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.08% |
| % Dimiliki oleh Institusi | 34.20% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 22.00 (JMP Securities, 72.01%) | Beli |
| Median | 17.00 (32.92%) | |
| Rendah | 15.00 (D. Boral Capital, 17.28%) | Beli |
| Purata | 18.20 (42.30%) | |
| Jumlah | 5 Beli | |
| Harga Purata @ Panggilan | 13.85 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| JMP Securities | 09 Sep 2025 | 22.00 (72.01%) | Beli | 13.03 |
| HC Wainwright & Co. | 08 Aug 2025 | 17.00 (32.92%) | Beli | 10.33 |
| 30 Jun 2025 | 20.00 (56.37%) | Beli | 12.32 | |
| Needham | 24 Jun 2025 | 20.00 (56.37%) | Beli | 15.72 |
| D. Boral Capital | 23 Jun 2025 | 15.00 (17.28%) | Beli | 16.56 |
| RBC Capital | 20 Jun 2025 | 17.00 (32.92%) | Beli | 13.61 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| HURLBURT ELIZABETH | - | 13.06 | -53,997 | -706,048 |
| ZELNICK KAUFMAN BETH | - | 13.03 | -50,000 | -651,500 |
| Jumlah Keseluruhan Kuantiti Bersih | -103,997 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,357,548 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 13.05 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| HURLBURT ELIZABETH | Pegawai | 11 Sep 2025 | Jual (-) | 41,121 | 13.09 | 538,274 |
| HURLBURT ELIZABETH | Pegawai | 11 Sep 2025 | Pelaksanaan pilihan | 41,121 | - | - |
| HURLBURT ELIZABETH | Pegawai | 09 Sep 2025 | Jual (-) | 12,876 | 13.03 | 167,774 |
| HURLBURT ELIZABETH | Pegawai | 09 Sep 2025 | Pelaksanaan pilihan | 12,876 | - | - |
| ZELNICK KAUFMAN BETH | Pegawai | 09 Sep 2025 | Jual (-) | 50,000 | 13.03 | 651,500 |
| ZELNICK KAUFMAN BETH | Pegawai | 09 Sep 2025 | Pelaksanaan pilihan | 50,000 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |